UBS Group’s Haoxi Health Technology Ltd HAO Stock Holding History

UBS Group’s Portfolio HAO Stock Details HAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468	Buy	4 +1	+33%	+$161	﹤0.01%	9877
2025 Q4	$396	Buy	+3	New	+$408	﹤0.01%	9988
2025 Q3	–	Sell	-35	Closed	-$5.9K	–	11045
2025 Q2	$5.9K	Sell	35 -113	-76%	-$19.1K	﹤0.01%	9128
2025 Q1	$23.9K	Buy	148 +45	+44%	+$13.3K	﹤0.01%	8104
2024 Q4	$49.2K	Buy	103 +78	+312%	+$44.6K	﹤0.01%	7309
2024 Q3	$28.4K	Buy	25 +22	+733%	+$259K	﹤0.01%	7150
2024 Q2	$57.1K	Buy	+3	New	+$59K	﹤0.01%	6592
2024 Q1	–	Hold	0	–	–	–	8517

Other funds holding HAO

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

UBS Group's HAO Position: Q1 2026 in Review

UBS Group increased its Haoxi Health Technology Ltd (HAO) stake by 33% in Q1 2026, buying an estimated $161 and bringing the position to 4 shares worth $468. The position accounts for ﹤0.01% of the portfolio, ranked #9877.

UBS Group first reported a position in HAO in Q2 2024 and has held it in 7 quarters since. The position peaked at $57.1K in Q2 2024. 2 funds tracked by Wall St. Rank hold HAO as of Q1 2026.

UBS Group held 4 shares of Haoxi Health Technology Ltd worth $468 as of Q1 2026.
UBS Group bought 1 Haoxi Health Technology Ltd share in Q1 2026, an estimated $161.
Haoxi Health Technology Ltd made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9877 holding.
UBS Group first reported a position in Haoxi Health Technology Ltd in Q2 2024 and has held it in 7 quarters since.
UBS Group's Haoxi Health Technology Ltd position peaked at $57.1K in Q2 2024.
2 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.